A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Clinical trial NCT06513884 · WITHDRAWN

Trial details

NCT number: NCT06513884
Sponsor: Hookipa Biotech GmbH
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Oropharyngeal Squamous Cell Carcinoma Recurrent

Start date: 2024-12-01
Primary completion: 2029-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.